Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Julia Danko
Julia Danko, MPAS, PA-C
The goal of HCT is to cure an underlying malignancy or hematologic disorder. The procedure can be performed in an inpatient or outpatient setting. Each setting is associated with its own risks and benefits.
Heather Adams, MPAS, PA-C
The goal of HCT is to cure an underlying malignancy or hematologic disorder. The procedure can be performed in an inpatient or outpatient setting. Each setting is associated with its own risks and benefits.
Hematopoietic Cell Transplant: Review for Primary Care Providers
Hematopoietic cell transplant (HCT) is a potentially curative treatment for hematologic malignancies, autoimmune disorders, and blood dyscrasias.1 Hematopoietic stem cells can be collected from and administered to the same patient, known as autologous HCT, or collected from a donor and administered to a patient, known as allogeneic HCT. Both approaches use cells harvested from the peripheral blood, bone marrow, or umbilical cord blood.
Hematopoietic Cell Transplant: Review for Primary Care Providers
Hematopoietic cell transplant (HCT) is a potentially curative treatment for hematologic malignancies, autoimmune disorders, and blood dyscrasias.1 Hematopoietic stem cells can be collected from and administered to the same patient, known as autologous HCT, or collected from a donor and administered to a patient, known as allogeneic HCT. Both approaches use cells harvested from the peripheral blood, bone marrow, or umbilical cord blood.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Julia
Contact Julia, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack